Effects of propidium monoazide (PMA) treatment on mycobiome and bacteriome analysis of cystic fibrosis airways during exacerbation

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Nguyen, Linh Do Ngoc ^a   Deschaght, Pieter ^b   Merlin, Sophie ^c,d   Loywick, Alexandre ^c,d   Audebert, Christophe ^c,d   Van Daele, Sabine ^b   Viscogliosi, Eric ^a   Vaneechoutte, Mario ^b   Delhaes, Laurence ^a,e,f  

^a UNIV LILLE   (France)

^b GHENT UNIVERSITY   (Belgium)

^c Genes Diffusion   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZIDE; PROPIDIUM MONOAZIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; PROPIDIUM IODIDE;

ARTICLE; BACTERIAL GENE; BACTERIOME; BACTERIUM; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG EFFICACY; FOLLOW UP; FUNGAL COMMUNITY; GENE EXPRESSION; HIGH THROUGHPUT SEQUENCING; HUMAN; LUNG INFECTION; MICROBIAL COMMUNITY; MYCOBIOME; NONHUMAN; SPECIES DIVERSITY; SPUTUM ANALYSIS; ADOLESCENT; ADULT; ANALOGS AND DERIVATIVES; BIODIVERSITY; DISEASE COURSE; DRUG EFFECTS; FEMALE; FORCED EXPIRATORY VOLUME; GENETICS; LUNG; MALE; METABOLISM; METAGENOME; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RESPIRATORY SYSTEM; SPUTUM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZIDES; BIODIVERSITY; CYSTIC FIBROSIS; DISEASE PROGRESSION; DNA, BACTERIAL; FEMALE; FORCED EXPIRATORY VOLUME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG; MALE; METAGENOME; MICROBIOTA; MIDDLE AGED; MYCOBIOME; PROPIDIUM; PROSPECTIVE STUDIES; RESPIRATORY SYSTEM; SPUTUM; YOUNG ADULT;

EID: 85007373429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168860     Document Type: Article

References (53)

1. Stenbit AE, Flume PA. Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med. 2011; 17: 442-447. PMID: 21881509
2. Ratjen F, McColley SA. Update in cystic fibrosis 2011. Am J Respir Crit Care Med. 2012; 185: 933-936. doi: 10.1164/rccm.201202-0306UP PMID: 22550209
3. Whiteson KL, Simone M, Lim YW, Schmieder R, Maughan H, Quinn R, et al. Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2, 3-butanedione fermentation. ISME J. 2014; 8: 1247-1258. doi: 10.1038/ismej.2013.229 PMID: 24401860
4. Quinn RA, Whiteson K, Lim Y-W, Salamon P, Bailey B, Mienardi S, et al. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation. ISME J. Nature Publishing Group; 2014; 9: 1024-1038.
5. Surette MG. The cystic fibrosis lung microbiome. Ann Am Thorac Soc. 2014; 11: 61-65.
6. Rogers GB, Cuthbertson L, Hoffman LR, Wing PA, Pope C, Hooftman DA, et al. Reducing bias in bacterial community analysis of lower respiratory infections. ISME J. Nature Publishing Group; 2013; 7: 697-706.
7. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A. 2012; 109: 5809-5814. doi: 10.1073/pnas.1120577109 PMID: 22451929
8. Rogers GB, Stressmann FA, Koller G, Daniels T, Carroll MP, Bruce KD. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagn Microbiol Infect Dis. 2008; 62: 133-141. doi: 10.1016/j.diagmicrobio.2008.06.011 PMID: 18692341
9. Vesper S, McKinstry C, Hartmann C, Neace M, Yoder S, Vesper A. Quantifying fungal viability in air and water samples using quantitative PCR after treatment with propidium monoazide (PMA). J Microbiol Methods. 2008; 72: 180-184. doi: 10.1016/j.mimet.2007.11.017 PMID: 18160156
10. Agustí G, Fittipaldi M, Morató J, Codony F. Viable quantitative PCR for assessing the response of Candida albicans to antifungal treatment. Appl Microbiol Biotechnol. 2013; 97: 341-349. doi: 10.1007/ s00253-012-4524-z PMID: 23132341
11. Chiao T, Clancy TM, Pinto A, Xi C, Raskin L. Differential resistance of drinking water bacterial populations to monochloramine disinfection. Environ Sci Technol. 2014; 48: 4038-4047. doi: 10.1021/ es4055725 PMID: 24625288
12. Vaishampayan P, Probst AJ, La Duc MT, Bargoma E, Benardini JN, Andersen GL, et al. New perspectives on viable microbial communities in low-biomass cleanroom environments. ISME J. Nature Publishing Group; 2013; 7: 312-324.
13. Nocker A, Richter-Heitmann T, Montijn R, Schuren F, Kort R. Discrimination between live and dead cells in bacterial communities from environmental water samples analyzed by 454 pyrosequencing. Int Microbiol. 2010; 13: 59-65. PMID: 20890840
14. Exterkate RAM, Zaura E, Brandt BW, Buijs MJ, Koopman JE, Crielaard W, et al. The effect of propidium monoazide treatment on the measured bacterial composition of clinical samples after the use of a mouthwash. Clin Oral Investig. 2014; 19: 813-822. doi: 10.1007/s00784-014-1297-z PMID: 25106845
15. Venkateswaran K, Vaishampayan P, Cisneros J, Pierson DL, Rogers SO, Perry J. International Space Station environmental microbiome-microbial inventories of ISS filter debris. Appl Microbiol Biotechnol. 2014; 98: 6453-6466. doi: 10.1007/s00253-014-5650-6 PMID: 24695826
16. Deschaght P, Schelstraete P, Lopes dos Santos Santiago G, Van Simaey L, Haerynck F, Van Daele S, et al. Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients. BMC Microbiol. 2010; 10: 245. doi: 10.1186/1471-2180-10-245 PMID: 20868481
17. Deschaght P, Schelstraete P, Van Simaey L, Vanderkercken M, Raman A, Mahieu L, et al. Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load? PLoS One. 2013; 8: e79010. doi: 10.1371/journal.pone.0079010 PMID: 24312174
18. Fré alle E, Decrucq K, Botterel F, Bouchindhomme B, Camus D, Dei-Cas E, et al. Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: Influence of bronchoalveolar lavage human DNA content on real-time PCR performance. Eur J Clin Microbiol Infect Dis. 2009; 28: 223-232. doi: 10.1007/s10096-008-0616-1 PMID: 18763000
19. Toju H, Tanabe AS, Yamamoto S, Sato H. High-coverage ITS primers for the DNA-based identification of ascomycetes and basidiomycetes in environmental samples. PLoS One. 2012; 7: e40863. doi: 10. 1371/journal.pone.0040863 PMID: 22808280
20. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: opensource, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009; 75: 7537-7541. doi: 10.1128/AEM.01541-09 PMID: 19801464
21. Cai Y, Sun Y. ESPRIT-Tree: hierarchical clustering analysis of millions of 16S rRNA pyrosequences in quasilinear computational time. Nucleic Acids Res. 2011; 39: e95. doi: 10.1093/nar/gkr349 PMID: 21596775
22. McDonald D, Clemente JC, Kuczynski J, Rideout JR, Stombaugh J, Wendel D, et al. The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. Gigascience. 2012; 1: 7. doi: 10.1186/2047-217X-1-7 PMID: 23587224
23. Goecks J, Nekrutenko A, Taylor J. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 2010; 11: R86. doi: 10.1186/gb-2010-11-8-r86 PMID: 20738864
24. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007; 35: 7188-7196. doi: 10.1093/nar/gkm864 PMID: 17947321
25. Delhaes L, Monchy S, Fréalle E, Hubans C, Salleron J, Leroy S, et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS One. 2012; 7: e36313. doi: 10.1371/journal.pone.0036313 PMID: 22558432
26. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, Aitken ML, et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci U S A. 2012; 109: 13769-13774. doi: 10.1073/pnas.1107435109 PMID: 22872870
27. Logares R, Audic S, Bass D, Bittner L, Boutte C, Christen R, et al. Patterns of rare and abundant marine microbial eukaryotes. Curr Biol. 2014; 24: 813-821. doi: 10.1016/j.cub.2014.02.050 PMID: 24704080
28. Galand PE, Casamayor EO, Kirchman DL, Lovejoy C. Ecology of the rare microbial biosphere of the Arctic Ocean. Proc Natl Acad Sci U S A. 2009; 106: 22427-22432. doi: 10.1073/pnas.0908284106 PMID: 20018741
29. Hammer Ø, Harper DAT, Ryan PD. Past: Paleontological statistics software package for education and data analysis. 2001; 4: 1-9.
30. Baxter CG, Dunn G, Jones AM, Webb K, Gore R, Richardson MD, et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. Elsevier Ltd; 2013; 132: 560-566. e10.
31. Høiby N, Ciofu O, Bjarnsholt T. Pseudomonas aeruginosa biofilms in Cystic Fibrosis. Future Microbiol. 2010; 5: 1663-1674. doi: 10.2217/fmb.10.125 PMID: 21133688
32. Waters VJ, Stanojevic S, Sonneveld N, Klingel M, Grasemann H, Yau YCW, et al. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. J Cyst Fibros. Elsevier B.V.; 2015; 1-8.
33. Méar JB, Kipnis E, Faure E, Dessein R, Schurtz G, Faure K, et al. Candida albicans and Pseudomonas aeruginosa interactions: More than an opportunistic criminal association? Med Mal Infect. Elsevier Masson SAS; 2013; 43: 146-151.
34. Manavathu EK, Vager DL, Vazquez JA. Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa. BMC Microbiol. BMC Microbiology; 2014; 14: 53. doi: 10.1186/1471-2180-14-53 PMID: 24588809
35. Tavernier S, Coenye T. Quantification of Pseudomonas aeruginosa in multispecies biofilms using PMAqPCR. PeerJ. 2015; 3: e787. doi: 10.7717/peerj.787 PMID: 25755923
36. Nguyen LDN, Viscogliosi E, Delhaes L. The lung mycobiome: an emerging field of the human respiratory microbiome. Front Microbiol. 2015; 6: 1-9.
37. Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc. 2015; 12: 821-830. doi: 10.1513/AnnalsATS.201501-029OC PMID: 25803243
38. Venkataraman A, Bassis CM, Beck JM, Young VB, Curtis JL, Huffnagle GB, et al. Application of a neutral community model to assess structuring of the human lung microbiome. MBio. 2015; 6: 1-9.
39. Marsland BJ, Gollwitzer ES. Host-microorganism interactions in lung diseases. Nat Rev Immunol. Nature Publishing Group; 2014; 14: 827-835.
40. Whiley RA, Fleming E V., Makhija R, Waite RD. Environment and colonisation sequence are key parameters driving cooperation and competition between Pseudomonas aeruginosa cystic fibrosis strains and oral commensal streptococci. PLoS One. 2015; 10: 1-14.
41. Touati K, Nguyen LDN, Delhaes L. The airway colonization by opportunistic filamentous fungi in patients with cystic fibrosis: recent updates. Curr Fungal Infect Rep. 2014; 8: 302-311.
42. Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, Morrison HG, et al. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome. 2014; 2: 40. doi: 10.1186/2049-2618-2-40 PMID: 25408892
43. van Woerden HC, Gregory C, Brown R, Marchesi JR, Hoogendoorn B, Matthews IP. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect Dis. BMC Infectious Diseases; 2013; 13: 69. doi: 10.1186/1471-2334-13-69 PMID: 23384395
44. Charlson E, Diamond JM, Bittinger K, Fitzgerald AS, Yadav A, Haas AR, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med. 2012; 186: 536-545. doi: 10.1164/rccm.201204-0693OC PMID: 22798321
45. Kurtzman C. Phylogenetic circumscription of Saccharomyces, Kluyveromyces and other members of the Saccharomycetaceae, and the proposal of the new genera Lachancea, Nakaseomyces, Naumovia, Vanderwaltozyma and Zygotorulaspora. FEMS Yeast Res. 2003; 4: 233-245. PMID: 14654427
46. Taylor MJ, Bentham RH, Ross KE. Limitations of using propidium monoazide with qPCR to discriminate between live and dead Legionella in biofilm samples. Microbiol Insights. 2014; 7: 15-24. doi: 10.4137/ MBI.S17723 PMID: 25288885
47. Fittipaldi M, Nocker A, Codony F. Progress in understanding preferential detection of live cells using viability dyes in combination with DNA amplification. J Microbiol Methods. Elsevier B.V.; 2012; 91: 276-289.
48. Mangot J-F, Domaizon I, Taib N, Marouni N, Duffaud E, Bronner G, et al. Short-term dynamics of diversity patterns: evidence of continual reassembly within lacustrine small eukaryotes. Environ Microbiol. 2013; 15: 1745-1758. doi: 10.1111/1462-2920.12065 PMID: 23297806
49. Quero GM, Luna GM. Diversity of rare and abundant bacteria in surface waters of the Southern Adriatic Sea. Mar Genomics. Elsevier B.V.; 2014; 17: 9-15.
50. Filkins LM, Hampton TH, Gifford AH, Gross MJ, Hogan DA, Sogin ML, et al. Prevalence of Streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol. 2012; 194: 4709-4017. doi: 10.1128/JB.00566-12 PMID: 22753064
51. Roux D, Gaudry S, Dreyfuss D, El-Benna J, de Prost N, Denamur E, et al. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med. 2009; 37: 1062-1067. PMID: 19237918
52. Xu H, Sobue T, Thompson A, Xie Z, Poon K, Ricker A, et al. Streptococcal co-infection augments candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microbiol. 2014; 16: 214-231. doi: 10.1111/cmi.12216 PMID: 24079976
53. Peleg AY, Hogan D., Mylonakis E. Medically important bacterial-fungal interactions. Nat Rev Microbiol. Nature Publishing Group; 2010; 8: 340-349.